Search

IQVIA hopes to help clinical trial sites rein in the number of software systems they have to manage by putting them behind a single dashboard. [ABSTRACT FROM AUTHOR]

After beginning the U.S. launch of its AspyreRx digital therapeutic for Type 2 diabetes last fall, Better Therapeutics is ramping up that rollout. [ABSTRACT FROM AUTHOR]

With its new FDA clearance, Huma's health management software can now be more direct in offering clinical recommendations to users and their doctors. [ABSTRACT FROM AUTHOR]

GlucoContro.online allows patients to dig even deeper into the data collected by Ascensia's Contour blood glucose monitoring devices. [ABSTRACT FROM AUTHOR]

Making good on its pledge to expand the reach of Project Baseline, its clinical research platform, Verily is set to acquire SignalPath, developer of an eponymous platform that, like Baseline, aims to make the entire clinical trial process more efficient. [ABSTRACT FROM AUTHOR]

While preparing for the Pulse platform's European debut this summer, NuVasive will also be awaiting regulatory approval on the far side of the Atlantic. The technology was initially cleared by the FDA in 2018, but the company opted to hold off on its U.S. rollout at the time in favor of adding additional capabilities to the system. [ABSTRACT FROM AUTHOR]

A massive database of real-world evidence—encompassing electronic health records, lab test results, medical claims and other information from more than 330 million patients across the U.S.—is about to get even bigger. [ABSTRACT FROM AUTHOR]